Zoekresultaten - 21 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
versions: DOI: https://sciensano.be/en/10.2900/98171 File: Version: Published Full text access: Public Access Full text language: English Category: E12 FOS Classification: 3.03 Health sciences ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
versions: DOI: https://sciensano.be/en/10.1186/s13104-023-06608-4 File: Version: Published Full text access: Public Access Full text language: English Category: A1 FOS Classification: 3.03 Health ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
versions: DOI: https://sciensano.be/en/10.1111/irv.13195 File: Version: Published Full text access: Public Access Full text language: English Category: A1 FOS Classification: 3.03 Health sciences ...
aP serology change from RP to GMU for Hexaxim and Tetravac
Vaccin Vaccin Service: Qualité des vaccins et produits sanguins Kwaliteit van vaccins en bloedproducten Quality of vaccines and blood products Full text language: English Category: C31 FOS ...
Replacement of Diphtheria and Tetanus potency challenge method by serology in mice
Topics: Vaccin Vaccin Vaccin Service: Qualité des vaccins et produits sanguins Kwaliteit van vaccins en bloedproducten Quality of vaccines and blood products Full text language: English Category: C31 FOS ...
Vaccinatiegraad en epidemiologische impact van de COVID-19-vaccinatiecampagne bij personen met onderliggende gezondheidsaandoeningen in België
populatie met onderliggende aandoeningen die geassocieerd zijn met een groter risico op het ontwikkelen van ernstige COVID-19 in België te beschrijven en om voor deze groep de vaccinatiegraad en de ...
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 chez les personnes présentant des maladies sous-jacentes en Belgique
sous-jacente, peut s’expliquer en partie par l’âge. Les taux de vaccination des personnes de 65 ans et plus étaient relativement similaires qu’elles soient atteintes ou non de pathologie sous-jacente. Cependant, ...
Characterisation of tetanus monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
et produits sanguins Kwaliteit van vaccins en bloedproducten Quality of vaccines and blood products Manuscript versions: DOI: https://pubmed.ncbi.nlm.nih.gov/33454193/ File: Version: Published Full ...
Characterisation of diphtheria monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
Kwaliteit van vaccins en bloedproducten Quality of vaccines and blood products Manuscript versions: DOI: https://pubmed.ncbi.nlm.nih.gov/33454193/ File: Version: Published Full text access: Public Access ...
Evaluation of quality and non-clinical data for licencing of vaccines
Quality vaccine vaccines WHO Health Topics: Vaccin Vaccin Vaccin Efficacité et sécurité des vaccins, médicaments et produits de santé- Qualité des laboratoires médicaux Doeltreffendheid en veiligheid van ...